Clarendon Private LLC Acquires New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Clarendon Private LLC has made a noteworthy investment by acquiring a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter. This information comes from the firm's latest 13F filing with the Securities and Exchange Commission (SEC). Clarendon Private LLC purchased 955 shares of this leading medical equipment provider, which are valued at approximately $498,000.

Recently, other institutional investors and hedge funds have also engaged in buying and selling shares of Intuitive Surgical. For instance, State Street Corp increased its stake by 1.4% during the third quarter, accumulating a total of 15,050,121 shares worth around $7.39 billion after acquiring an additional 210,363 shares in the last quarter. Similarly, FMR LLC expanded its holdings by 8.3% during the same period and now owns 10,971,085 shares valued at about $5.39 billion after adding 838,793 shares.

Another investment firm, Geode Capital Management LLC, increased its position by 1.9% in the third quarter, resulting in ownership of 7,512,925 shares worth roughly $3.68 billion after acquiring an additional 143,440 shares. Additionally, Fisher Asset Management LLC raised its position by 1.8%, holding now 4,782,381 shares, which are valued at approximately $2.35 billion after purchasing an additional 86,208 shares.

Baillie Gifford & Co. also contributed by raising its holdings by 0.6%. Now, they own 3,848,547 shares valued at around $1.89 billion after acquiring an extra 24,183 shares. Collectively, institutional investors own about 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In related news, there have been some insider transactions at Intuitive Surgical. Chief Financial Officer Jamie Samath sold 270 shares on December 10, valued at approximately $145,840.50, with an average selling price of $540.15; after this transaction, the CFO now owns 8,757 shares valued at around $4.73 million, representing a 2.99% decrease in their ownership.

Moreover, CEO Gary S. Guthart sold 18,151 shares on October 30, receiving about $9.29 million from the sale at an average price of $511.63. Post-transaction, the CEO holds 24,219 shares worth around $12.39 million, marking a 42.84% decrease in ownership. In the past three months, insiders have collectively sold 42,475 shares valued at about $22.07 million, and company insiders currently own 0.90% of the stock.

Intuitive Surgical Stock Performance

As for stock performance, Intuitive Surgical shares opened at $584.05. The company boasts a market capitalization of $208.03 billion, with a price-to-earnings ratio of 93.90, a PEG ratio of 5.19, and a beta of 1.39. The fifty-day moving average of the stock is $547.16, while the 200-day moving average is $504.35. Over the last year, the stock has seen a low of $364.17 and a high of $616.00.

Market Analysts Express Opinions

Several market analysts have recently published reports on Intuitive Surgical. The Goldman Sachs Group set a price target of $604.00 in their report dated October 18. Oppenheimer reiterated a "market perform" rating on the shares on the same day. Additionally, Wells Fargo & Company raised its price objective from $630.00 to $687.00 and assigned an "overweight" rating in a research report on the same date. Furthermore, Morgan Stanley upgraded their rating from "equal weight" to "overweight" and increased their target price from $522.00 to $650.00 on December 2. Meanwhile, Raymond James boosted their target price from $560.00 to $688.00, providing an "outperform" rating.

In total, one research analyst rated the stock with a sell rating, three gave it a hold rating, and fifteen assigned a buy rating. According to MarketBeat data, the stock currently holds a consensus rating of "Moderate Buy" with a target price averaging $583.83.

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is engaged in developing, manufacturing, and marketing products designed to enhance the quality and accessibility of minimally invasive healthcare. The company is renowned for its da Vinci Surgical System, which allows complex surgeries with minimal invasiveness, along with its Ion endoluminal system that extends its analysis capabilities into diagnostic procedures for minimally invasive lung biopsies.

Investment, Shares, IntuitiveSurgical